Cytosar (cytarabinum) Barcode Expiry Date Discrepancy Alert
Summary
Swissmedic has issued a Health Professional Communication regarding a barcode expiry date discrepancy for Cytosar (cytarabinum) 2g/20ml, batch CT32407B. The date encoded in the 2D barcode on the vial label is incorrect and does not match the legible expiry date printed on the vial.
What changed
Swissmedic, the Swiss Agency for Therapeutic Products, has issued a Health Professional Communication (DHPC) concerning a specific batch of Cytosar (cytarabinum) 2g/20ml, batch number CT32407B. The issue identified is a discrepancy where the expiry date encoded in the 2D barcode on the vial label is incorrect and does not align with the legible expiry date printed on the vial itself. This alert pertains to a single affected batch, and further details are available in a separate company information letter.
Healthcare providers and potentially pharmaceutical distributors handling this specific batch should be aware of this discrepancy. While the legible expiry date on the vial is stated to be correct, the incorrect barcode information could lead to errors in inventory management or automated dispensing systems. It is recommended to consult the company's information letter for precise instructions and to ensure proper handling and dispensing of this medication to avoid potential patient safety issues arising from incorrect expiry date interpretation.
What to do next
- Review company information letter regarding Cytosar (cytarabinum) batch CT32407B
- Verify expiry dates on affected vials against legible print and barcode data
- Ensure proper handling and dispensing procedures are followed to account for the barcode discrepancy
Source document (simplified)
DHPC – Cytosar (cytarabinum)
Diskrepanz Barcode
18.02.2026
| Präparat | Cytosar 2g/20ml, Injektionslösung |
| --- | --- |
| Zulassungsnummer | 54845 |
| Wirkstoff | cytarabinum |
| Zulassungsinhaberin | Pfizer AG |
| Betroffene Charge | CT32407B |
Das im 2D-Barcode des Fläschchenetiketts kodierte Verfallsdatum ist falsch und stimmt nicht mit dem auf dem Fläschchenetikett aufgedrucktem lesbarem Format überein.
Weitere Informationen entnehmen Sie bitte dem Informationsschreiben der Firma.
- Company information letter
DHPC – Cytosar (cytarabinum) (PDF, 210 kB, 13.02.2026)
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Swissmedic Health Professional Communications publishes new changes.